Test Price
1,800 AED✅ Home Collection Available
Hepatitis B Viral Drug Resistance & Genotyping Test in UAE | 1800 AED | 2026 DHA Guidelines
تحليل مقاومة فيروس التهاب الكبد البائي للأدوية وتحديد النمط الجيني في الإمارات | 1800 درهم | معتمد من هيئة الصحة بدبي
Executive Clinical Assurance – UAE Trusted Diagnostics
- 99.9% Diagnostic Sensitivity – ISO 9001:2015 certified NGS sequencing, validated against 2026 DHA proficiency panels.
- Premium Home Collection – Hospital-grade, DHA‑licensed phlebotomists with ISO‑certified cold‑chain logistics (2–8°C). Same‑day collection available until 8 PM.
- Post‑Test Clinical Guidance – Complimentary 15‑minute tele‑consultation with a Gastroenterologist to interpret your genotypic resistance profile.
- Direct Insurance Billing – WhatsApp +971 54 548 8731 for real‑time coverage verification and pre‑authorisation.
ملخص تنفيذي: اختبار تسلسل الحمض النووي (NGS) لمقاومة فيروس التهاب الكبد البائي للأدوية وتحديد النمط الجيني بدقة 99.9%، معتمد من هيئة الصحة بدبي وموافق لدليل الممارسات السريرية لعام 2026. يشمل خدمة سحب منزلي معتمدة ونقل مبرد تحت الرقابة المخبرية، وتغطية تأمينية مباشرة عبر الواتساب.
Test Overview
The Hepatitis B Viral Drug Resistance & Genotyping test uses next‑generation sequencing (NGS) to identify HBV genotypes (A–J) and detect resistance mutations to antivirals such as lamivudine, adefovir, entecavir, and tenofovir, critical for tailoring therapy in chronic hepatitis B. يكشف هذا الفحص عن الطفرات الجينية المسببة لمقاومة الأدوية ويحدد النمط الجيني الفيروسي لتحسين خطة العلاج.
| Feature | Our Test (AMERICAN BOARD OF PATHOLOGY MONITORED) | Standard Genotyping Only |
|---|---|---|
| Methodology | NGS (Illumina® platform) – full reverse transcriptase region | Sanger sequencing (limited to partial genome) |
| Drug Resistance Genes Covered | rtA194T, rtL180M, rtM204V/I ± others; all clinically relevant variants | May miss low‑frequency variants; only genotype |
| Turnaround Time | 7 days (sample accepted daily until 11 AM) | 10–14 days |
| UAE Regulatory | DHA/MOHAP approved, ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Variable accreditation |
Physician Insight & Patient Safety Protocol
“As a DHA‑licensed Gastroenterologist (Licence 61713011), I emphasise that HBV genotyping and resistance testing is not a screening tool. It must be interpreted alongside HBV DNA levels, liver enzymes, and clinical history. A negative resistance report does not exclude poor compliance or evolving viral quasispecies. Never alter treatment without consulting your hepatologist.”
— Dr. PRABHAKAR REDDY
⚠ CLINICAL SAFETY ALERT
- Do not discontinue prescribed antiviral medication without explicit instruction from your treating physician; abrupt cessation can cause severe hepatitis flare.
- This test requires a plasmid level ≥3 mL collected in 2 Lavender Top (EDTA) tubes, separated aseptically within 2 hours and shipped refrigerated or frozen. Improper handling leads to sample rejection.
- Exclusion criteria: Patients with decompensated cirrhosis, active hepatic encephalopathy, or those on direct‑acting anticoagulants (DOACs) with INR >2.5 must be stabilised in a supervised setting before elective phlebotomy.
- ER red flags: Sudden onset of jaundice, ascites, confusion, or haematemesis require immediate emergency care – call 998 for UAE ambulance. Home collection is not a substitute for emergency evaluation.
Frequently Asked Questions
1. Who should order the Hepatitis B Drug Resistance & Genotyping test?
This advanced molecular test is prescribed for adults on long‑term oral antiviral therapy who exhibit virological breakthrough (persistent HBV DNA >2000 IU/mL after initial suppression) or for treatment‑naïve patients with known high‑risk exposures to determine genotype‑specific therapy selection. يُوصى بهذا الفحص عند ظهور اختراق فيروسي أثناء العلاج طويل الأمد بمضادات الفيروسات.
2. What does the result report include?
Results detail the HBV genotype (e.g., A, D, E), list any detected drug resistance mutations (with ClinVar annotations), and provide an interpretive guide aligning with current EASL/AASLD 2026 treatment guidelines, helping your physician select the most effective antiviral regimen. يتضمن التقرير النمط الجيني والطفرات المقاومة للأدوية مع تفسير سريري يستند إلى الإرشادات العالمية.
3. Is any special preparation required before the blood draw?
No fasting or dietary restrictions are needed; however, inform the home collection team about all current medications and recent immunisations. A certified phlebotomist will collect 3 mL of plasma in a cold‑chain ready kit, and you may resume normal activities immediately. لا حاجة للصيام، ولكن يجب إبلاغ طاقم السحب المنزلي بجميع الأدوية الحالية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians